Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7
Holding DE:RV7?
Track your performance easily
Summary of all the Indicators
Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Halozyme Therapeutics’s (RV7) Moving Averages Convergence Divergence (MACD) indicator is 1.74, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (RV7) 20-Day exponential moving average is 53.17, while Halozyme Therapeutics’s (RV7) share price is €55.52, making it a Buy.
Halozyme Therapeutics’s (RV7) 50-Day exponential moving average is 50.26, while Halozyme Therapeutics’s (RV7) share price is €55.52, making it a Buy.
Halozyme (RV7) Pivot Points
Classic
56.22
56.38
56.70
56.86
57.18
57.34
57.66
Fibonacci
56.38
56.56
56.68
56.86
57.04
57.16
57.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Halozyme (RV7) Moving Averages
MA5
55.65Sell
55.56Sell
MA10
54.64Buy
54.61Buy
MA20
52.30Buy
53.17Buy
MA50
50.42Buy
50.26Buy
MA100
45.18Buy
46.61Buy
MA200
40.06Buy
42.13Buy
Halozyme Therapeutics’s (RV7) 10-Day exponential moving average is 54.61, while Halozyme Therapeutics’s (RV7) share price is €55.52, making it a Buy.
Halozyme Therapeutics’s (RV7) 100-Day exponential moving average is 46.61, while Halozyme Therapeutics’s (RV7) share price is €55.52, making it a Buy.
Halozyme Therapeutics’s (RV7) stock price is €55.52 and Halozyme Therapeutics’s (RV7) 50-day simple moving average is 50.42, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €55.52 and Halozyme Therapeutics’s (RV7) 100-day simple moving average is 45.18, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €55.52 and Halozyme Therapeutics’s (RV7) 200-day simple moving average is 40.06, creating a Buy signal.
Halozyme (RV7) Technical Indicators
RSI (14)
62.40
Neutral
STOCH (9,6)
87.83
Sell
STOCHRSI (14)
92.29
Sell
MACD (12,26)
1.74
Sell
ADX (14)
27.67
Neutral
Williams %R
-19.43
Sell
CCI (14)
91.77
Neutral
ATR (14)
1.04
-
Ultimate Oscillator
65.73
Neutral
ROC
11.58
Buy
Halozyme Therapeutics’s (RV7) Relative Strength Index (RSI) is 62.40, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Trend Strength Indicator (ADX) is 27.67, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Commodity Channel Index (CCI) is 91.77, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Price Rate of Change (ROC) is 11.58, creating a Buy signal.
FAQ
Is RV7 a Buy, Hold, or Sell?
Based on RV7’s technical indicators, RV7 is a Buy.
What is RV7’s RSI (14)?
RV7’s RSI (14) is 62.40, which suggests RV7 is a Neutral.
What is RV7’s MACD?
RV7’s MACD is 1.74, which suggests RV7 is a Sell.
What is RV7’s 5-day moving average?
RV7’s 5-day moving average is 55.65, which suggests RV7 is a Sell.
What is RV7’s 20-day moving average?
RV7 20-day moving average is 52.30, which suggests RV7 is a Buy.
What is RV7’s 50-day moving average?
RV7’s 50-day moving average is 50.42, which suggests RV7 is a Buy.
What is RV7’s 200-day moving average?
RV7’s 200-day moving average is 40.06, which suggests RV7 is a Buy.
What is RV7’s Williams % R (14)?
RV7’s Williams % R (14) is -19.43, which suggests RV7 is a Sell.
What is RV7’s CCI (14)?
RV7’s CCI (14) is 91.77, which suggests RV7 is a Neutral.
What is the share price of Halozyme Therapeutics?
Halozyme's share price is 55.36€.